14-day Quadruple Therapy Versus Triple Therapy in HP Eradication

PHASE4CompletedINTERVENTIONAL
Enrollment

121

Participants

Timeline

Start Date

February 10, 2019

Primary Completion Date

February 17, 2020

Study Completion Date

March 5, 2020

Conditions
Gastritis H Pylori
Interventions
DRUG

metronidazole based quadriple therapy

patient randomized in QC will be treated by a double dose PPI (esomeprazole: 40 mg x 2 per day) in combination with amoxicillin (1 g x 2 per day), metronidazole (500 mg x 2 per day) and clarithromycin (500 mg x 2 per day)

DRUG

placebo based quadriple therapy

patient randomized in TT will be treated by double dose PPI (esomeprazole: 40 mg x 2 per day) in combination with amoxicillin (1 g x 2 per day), clarithromycin (500 mg x 2 per day) and a placebo of metronidazole.

Trial Locations (1)

Unknown

Fattouma Bourguiba Hospital, Monastir

All Listed Sponsors
lead

mohamed bouchoucha

INDUSTRY

NCT04769583 - 14-day Quadruple Therapy Versus Triple Therapy in HP Eradication | Biotech Hunter | Biotech Hunter